Comparison between Jagsonpal Pharmaceuticals Buyback 2026 and Wipro Buyback 2026.
Jagsonpal Pharmaceuticals Buyback 2026 is a Tender Offer buyback proposed to list at NSE, BSE while Wipro Buyback 2026 is a Tender Offer proposed to list at BSE, NSE.
| Jagsonpal Pharmaceuticals Ltd. | Wipro Ltd. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Logo | ![]() | ![]() | ||||||||||||||||||
| Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
| Listing At | NSE, BSE | BSE, NSE | ||||||||||||||||||
| Face Value | ₹10 per share | ₹2 per share | ||||||||||||||||||
| Buyback Price | ₹250 per share | ₹250 per share | ||||||||||||||||||
| Issue Size | 16,00,000 shares | 60,00,00,000 shares | ||||||||||||||||||
| Issue Size (Amount) | ₹40.00 Crores | ₹15,000.00 Crores | ||||||||||||||||||
| Buyback Ratio |
Note:
|
Note:
| ||||||||||||||||||
| Registrar | MCS Share Transfer Agent Ltd. | Kfin Technologies Ltd. | ||||||||||||||||||
| Lead Managers | Centrum Capital Ltd. | JM Financial Ltd. | ||||||||||||||||||
| Necessity of the buyback | The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
Jagsonpal Pharmaceuticals Buyback 2026 and Wipro Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Jagsonpal Pharmaceuticals Buyback 2026 Buyback record date is May 04, 2026. Wipro Buyback 2026 Buyback record date is Jun 05, 2026.
| Jagsonpal Pharmaceuticals Ltd. | Wipro Ltd. | |
|---|---|---|
| Record Date | May 04, 2026 | Jun 05, 2026 |
| Offer Open Date | May 08, 2026 | Jun 11, 2026 |
| Offer Closure Date | May 14, 2026 | Jun 17, 2026 |
| Last date for receipt of tender forms | May 15, 2026 | Jun 17, 2026 |
| Finalisation of buyback | May 20, 2026 | Jun 23, 2026 |
| Last Date for settlment of bids | May 21, 2026 | Jun 24, 2026 |
| Last Date for extinguishment of shares | Jun 02, 2026 | Jul 06, 2026 |
Comparison of Jagsonpal Pharmaceuticals Buyback 2026 and Wipro Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
| Jagsonpal Pharmaceuticals Ltd. | Wipro Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Wipro Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2026 and March 31, 2025.
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Stock price at BSE | Stock price at BSE (in preceding 3 months)
| Stock price at BSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Stock price at NSE | Stock price at NSE (in preceding 3 months)
| Stock price at NSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||||||||||||||||